Hester Biosciences Ltd. News and Updates

Name: Latest research reports of Hester Biosciences Ltd. authored by ICICI Securities Limited and published by - Trendlyne research reports.
Item: Hester Biosciences Ltd.
Rating: 5
Author: ICICI Securities Limited

Keep track of all breaking news on Hester Biosciences Ltd. from all sources in a single place.

Load latest

Hester Biosciences Ltd.

12 Jun 2017

1978.10

-0.87%

Hester Biosciences to set up animal vaccines facility in Tanzania

Business Standard

Manufacturing facility will cater to entire Africa, which imports more than 80% of its vaccines

Hester Biosciences Ltd. is trading below its 30 day SMA of 2035.0

Hester Biosciences Ltd.

08 Jun 2017

1978.10

-0.87%

Hester Biosciences to invest $3 m in African subsidiary

Business Line

City-based animal healthcare player, Hester Biosciences Ltd on Thursday announced its plans to invest $3 million in its wholly-owned subsidiary in Africa Hester Biosciences Africa Limited, Tanzania.

Hester Biosciences Ltd.'s price crossed below 50Day SMA today

Hester Biosciences Ltd.

08 May 2017

1978.10

-0.87%

Hester Biosciences Q4 net up 29%

Business Line

City-based Hester Biosciences Ltd has posted a 29 per cent jump in net profit for the fourth quarter ended March 31, 2017, at Rs 7.07 crore against Rs 5.50 crore in the same quarter a year ago....

Hester Biosciences Ltd. has gained 42.41% in the last 6 Months

Hester Biosciences Ltd.

29 Mar 2017

1978.10

-0.87%

Hester Biosciences

Buy: Hester Biosciences Ltd.

ICICI Securities Limited

Hester Biosciences Ltd. is trading below its 30 day SMA of 2035.0

Hester Biosciences Ltd.

19 Jan 2017

1978.10

-0.87%

Hester Biosciences Q3 net up 22%

Business Line

launches Brucella vaccine

Hester Biosciences Ltd.'s price crossed below 50Day SMA today

Hester Biosciences Ltd.

20 Dec 2016

1978.10

-0.87%

Hester Biosciences Ltd: Results In-Line with Expectations; N... (Dec 20, 2016)

Buy: Hester Biosciences Ltd.

Target

Karvy

Nepal Plant Commissioned: The PPR vaccines manufacturing facility in Nepal has started commercial operations and would be manufacturing PPR vaccines for exports primarily to African countries. Commissioning of plant was delayed because of which most of PPR sales are likely to occur in the year 2017E and thereafter. We believe that successful operations of this plant are expected to lead to manufacturing of safe and effective vaccines, and thus is a defining moment in the history of HesterBiosciences Ltd (HBL). PPR is a plague affecting Sheep and Goats.

Hester Biosciences Ltd.'s price crossed below 50Day SMA today

Hester Biosciences Ltd.

23 Oct 2016

1978.10

-0.87%

Hester to invest 30 cr in new unit

Business Line

Animal health firm Hester Biosciences plans to invest nearly 30 crore to set up a large unit for products. Our next goal is to invest and create our own large animal health products unit and...

Hester Biosciences Ltd. is trading below its 30 day SMA of 2035.0

Hester Biosciences Ltd.

20 Oct 2016

1978.10

-0.87%

Hester Biosciences dips post September quarter results

Business Standard

The stock dipped 7% to Rs 716, falling 9% from intra-day high on BSE.

Hester Biosciences Ltd.'s price crossed below 50Day SMA today

Hester Biosciences Ltd.

03 Aug 2016

1978.10

-0.87%

Hester Biosciences Ltd 1QFY17 result update

Hold: Hester Biosciences Ltd.

BOB Capital Markets Ltd.

Hester Biosciences Ltd. posted robust growth in 1QFY17 with revenue growth of 22.8%/6.9% YoY/QoQ, respectively, to Rs 301mn led by 21.6%/41% growth in poultry segment/Large animal segment. EBITDA for the quarter grew by 31%/9.8% YoY/QoQ respectively to Rs 107mn with the expansion in EBITDA margins by 222/94bps YoY/QoQ to 35.5% mainly due to shift in product mix, better inventory management, credit control and lower financing cost.

Hester Biosciences Ltd. has gained 42.41% in the last 6 Months

Hester Biosciences Ltd.

29 Jul 2016

1978.10

-0.87%

Hester Bio Q1 net up 29%

Business Line

Animal healthcare player Hester Biosciences has posted a 29 per cent rise in net profit at Rs 5.99 crore for the first quarter ended June 2016, against Rs 4.66 crore in the same period last year. ...

Hester Biosciences Ltd.'s price crossed below 50Day SMA today

Is Hester Biosciences Ltd. worth buying?

81 Votes:

Buy 80.25%

Sell 11.11%

Hold 8.64%

29.00% Fall from 52W High

Hester Biosciences Ltd. News and Updates

Keep track of all breaking news on Hester Biosciences Ltd. from all sources in a single place.